Vikram Thermo , a company operating in the pharma polymers segment, has reported a significant increase in its financial performance for the quarter ended September 30, 2025.

Financial Highlights

• Net Profit: The company's net profit rose to ₹1,107.66 crore, marking a 39% increase from ₹794.13 crore in the same period last year.
• Revenue: Revenue from operations increased to ₹3,463.53 crore, up from ₹2,860.46 crore in the previous year's quarter.
• Half-Year Performance: For the half-year period, Vikram Thermo posted a profit of ₹1,901.79 crore on revenue of ₹6,323.99 crore.

Key Financial Metrics

Balance Sheet Highlights

As of September 30, 2025:

• Total Assets: ₹16,513.09 crore
• Total Equity: ₹13,731.90 crore
• Current Assets: ₹7,504.50 crore
• Current Liabilities: ₹2,474.89 crore

Management Commentary

The Board of Directors approved these unaudited financial results at their meeting held on November 11, 2025. The company operates solely in the pharma polymers segment and has no subsidiary, associate, or joint venture companies.

Corporate Governance

The audit committee reviewed and recommended the financial results, which were subsequently approved by the Board of Directors. The statutory auditors have expressed an unmodified audit opinion on the financial statements.

Investor Information

Vikram Thermo's equity shares are listed on the BSE. The company's financial results and other disclosures are available on the BSE website and the company's official website.

This strong quarterly performance demonstrates Vikram Thermo's growth in the pharma polymers sector. The company's consistent profit growth and solid balance sheet position are noteworthy aspects of this financial report.

Vikram Thermo (India) Limited , a leading manufacturer of pharmaceutical excipients and chemicals, has announced its 31st Annual General Meeting (AGM) and set the record date for dividend eligibility.

Key Highlights

• The 31st AGM is scheduled for Friday, September 26, 2025, at 11:00 AM through video conferencing.
• The company has declared a final dividend of 10% (Rs. 1.00 per equity share) for the financial year 2024-25.
• September 19, 2025, has been fixed as the record date for dividend entitlement.
• The Register of Members and Share Transfer Books will remain closed from September 20 to 26, 2025.

Dividend Details

Vikram Thermo's Board of Directors has recommended a final dividend of 10% (Rs. 1.00 per equity share) for the financial year 2024-25, subject to shareholder approval at the upcoming AGM. Shareholders whose names appear in the Register of Members as of September 19, 2025, will be eligible for the dividend.

AGM and E-voting Information

The 31st AGM will be conducted through video conferencing in compliance with regulatory guidelines. Shareholders can participate in the meeting and cast their votes electronically. The e-voting period will commence on Tuesday, September 23, 2025, at 9:00 AM and conclude on Thursday, September 25, 2025, at 5:00 PM.

Special Business

The AGM agenda includes special business items, such as:

1. Appointment of M/s. A. Shah & Associates as Secretarial Auditors for five consecutive financial years (2025-26 to 2029-30).
2. Ratification of remuneration for Cost Auditors M/S. Nisha Patel & Associates for the financial year 2025-26.

Additional Information

Shareholders are encouraged to review the complete AGM notice and annual report for detailed information on the company's performance and proposed resolutions. The AGM notice and related documents are available on the company's website at www.vikramthermo.com .

Vikram Thermo continues to focus on its core business of manufacturing pharmaceutical excipients and chemicals, with a strong emphasis on research and development to drive growth and innovation in the sector.